Polar Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Polar Capital’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-125,732	Closed	-$10.4M	–	336
2020 Q1	$10.4M	Buy	125,732 +21,227	+20%	+$2.07M	0.11%	165
2019 Q4	$11.6M	Sell	104,505 -19,895	-16%	-$2.05M	0.1%	189
2019 Q3	$12.3M	Buy	+124,400	New	+$12.4M	0.11%	183
2019 Q2	–	Sell	-492,854	Closed	-$54.4M	–	309
2019 Q1	$54.4M	Buy	492,854 +2,129	+0.4%	+$222K	0.5%	64
2018 Q4	$45.1M	Sell	490,725 -4,128	-0.8%	-$418K	0.48%	66
2018 Q3	$54.5M	Sell	494,853 -71,289	-13%	-$7.42M	0.46%	71
2018 Q2	$52.9K	Hold	566,142	–	–	0.32%	70
2018 Q1	$47M	Sell	566,142 -33,152	-6%	-$2.95M	0.47%	70
2017 Q4	$54.6M	Buy	+599,294	New	+$49.9M	0.56%	45

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Polar Capital's PRAH Position: Q2 2020 in Review

Polar Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2020, closing a stake of 125,732 shares — an estimated $10.4M sold.

Polar Capital first reported a position in PRAH in Q4 2017 and held it in 9 quarters. The position peaked at $54.6M in Q4 2017. 293 funds tracked by Wall St. Rank hold PRAH as of Q2 2020.

Polar Capital reported no remaining PRA Health Sciences, Inc. position as of Q2 2020 after selling out during the quarter.
Polar Capital sold 125,732 PRA Health Sciences, Inc. shares in Q2 2020, an estimated $10.4M.
Polar Capital first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 9 quarters.
Polar Capital's PRA Health Sciences, Inc. position peaked at $54.6M in Q4 2017.
293 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2020.

Based on Polar Capital's 13F filing for Q2 2020, filed 14 Aug 2020.